Connor M Forbes (Connor Forbes)

ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 7

Top Venues

The Prostate

The Journal of urology

Urolithiasis

Journal of educational evaluation for health professions

Vanderbilt University Medical Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Vanderbilt University Medical Center Jul 01 2020

United States

Endourology Fellow :: Urology

University of British Columbia Jul 01 2015 - Jun 30 2020

Canada

Urology Resident :: Urology

Publications

Renjie Jin, Connor M Forbes, Nicole L Miller, John T Lafin, Douglas W Strand, Thomas Case, Justin Merrill Marken Cates, Qi Liu, Marisol Ramirez-Solano, James L Mohler, Robert J Matusik
Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5-alpha reductase inhibitor resistance. The Prostate 84 (5) (2024)
Renjie Jin, Connor M Forbes, Nicole L Miller, John T Lafin, Douglas W Strand, Thomas Case, Justin Merrill Marken Cates, Qi Liu, Marisol Ramirez-Solano, James L Mohler, Robert J Matusik
Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5-alpha reductase inhibitor resistance. The Prostate 84 (5) (2024)
Ben Hall Chew, Jonathan D Harper, Roger L Sur, Thomas Chi, Shubha De, Anne R Buckley, Ryan F Paterson, Victor K F Wong, Connor M Forbes, M Kennedy Hall, Ross Kessler, Seth K Bechis, Jason R Woo, Ralph Charles Wang, David B Bayne, Derek Bochinski, Trevor D Schuler, Tim A Wollin, Rahim Samji, Mathew D Sorensen
Break Wave Lithotripsy for Urolithiasis: Results of the First-in-Human International Multi-Institutional Clinical Trial. The Journal of urology 212 (4) (2024)
Renjie Jin, Connor M Forbes, Nicole L Miller, John T Lafin, Douglas W Strand, Thomas Case, Justin Merrill Marken Cates, Qi Liu, Marisol Ramirez-Solano, James L Mohler, Robert J Matusik
Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5-alpha reductase inhibitor resistance. The Prostate (2024)
Renjie Jin, Connor M Forbes, Nicole L Miller, Douglas W Strand, Thomas Case, Justin Merrill Marken Cates, Hye-Young H Kim, Phillip A Wages, Ned A Porter, Krystin M Mantione, Sarah Burke, James L Mohler, Robert J Matusik
Glucocorticoids are induced while dihydrotestosterone levels are suppressed in 5-alpha reductase inhibitor treated human benign prostate hyperplasia patients. The Prostate 82 (14) (2022)
Connor M Forbes, Kemberlee Bonnet, Tracy Bryant, David G Schlundt, Kerri L Cavanaugh, Ryan S Hsi
Decision-making and improvements in health-related quality of life in patients with kidney stones: comparing surgery versus observation using a mixed methods analysis. Urolithiasis 50 (5) (2022)
RenJie Jin, Douglas W Strand, Connor M Forbes, Thomas Case, Justin M M Cates, Qi Liu, Marisol Ramirez-Solano, Ginger L Milne, Stephanie Sanchez, Zunyi Y Wang, Dale E Bjorling, Nicole L Miller, Robert J Matusik
The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms. The Prostate 81 (13) (2021)
Isabel Chen, Connor M Forbes
Reflective writing and its impact on empathy in medical education: systematic review. Journal of educational evaluation for health professions 11 (2014)

Connor M Forbes.css-eqlu8i{font-size:small;padding-left:4px;} (Connor Forbes)

Publication Activity (10 Years)

Top Topics

Top Venues

Connor M Forbes (Connor Forbes)